Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Corneal Transplantation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Indication End User" report has been added to ResearchAndMarkets.com's offering.
The corneal transplantation market is projected to reach $640.79 million by 2028 from $420.71 million in 2021; it is estimated to grow at a CAGR of 6.2% during 2021-2028. The report highlights trends prevailing in the market and factors driving its growth. The market's growth is attributed to the increasing incidence of eye diseases, and the rising geriatric population. However, the risks associated with Corneal Transplantation and shortage of donor material hampers the market growth.
Corneal blindness has complex epidemiology that includes a broad spectrum of infectious and inflammatory eye diseases causing corneal scars that contribute to functional blindness. Trachoma, corneal ulcers, ophthalmia neonatorum, xerophthalmia, viral infections, onchocerciasis, leprosy, traditional eye medications, and eye injuries lead to corneal blindness. According to the World Health Organization (WHO), 146 million people have trachoma, of which 10 million have trichiasis and require surgeries to prevent corneal blindness. In addition, ~4.9 million are completely blind due to trachomatous corneal scarring. Corneal blindness is preventable with the timely treatment of these diseases and better access to medical care. However, if left untreated at the initial stage, corneal transplantation is the only option for patients with damaged corneas.
According to 2020 statistics from the Cornea Research Foundation of America, keratoconus disorder affects ~50-200 out of every 100,000 people. These statistics suggest that the growing number of people suffering from keratoconus disease would boost the demand for corneal transplants. According to the Royal National Institute of Blind People (RNIB) statistics, ~4.1 million people in the UK will be affected by blindness during 2020-2050. As per the WHO, in 2021, ~2.2 billion people had near or far visual impairments - including 4.2 million people with corneal opacities. Thus, the growing incidence of eye diseases is bolstering the growth of the corneal transplantation market.
Based on type, the global corneal transplantation market has been segmented into penetrating keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and others. The penetrating keratoplasty segment held the largest share of the market in 2021 and is anticipated to register the CAGR of 6.4% in the market during the forecast period. Based on indication, the market is segmented into fungal corneal ulcer, Fuchs dystrophy, keratoconus, keratitis, and others. The Fuchs dystrophy segment held the largest share of the market in 2021 and is anticipated to register a CAGR of 6.8% in the market during the forecast period. Based on end user, the Corneal Transplantations market is segmented hospitals, eye clinics, and ambulatory surgical centers. The hospital segment held the largest share of the market in 2021 and is estimated to register the highest CAGR of 6.1% in the market during the forecast period.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global corneal transplantation market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global cornea transplantation market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Key Topics Covered:
1. Introduction
2. Key Takeaways
3. Research Methodology
4. Corneal Transplantation Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Corneal Transplantation Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Eye Diseases
5.1.2 Surge in Geriatric Population
5.2 Market Restraints
5.2.1 Risks Associated with Corneal Transplantation and Shortage of Donor Corneas
5.3 Market Opportunities
5.3.1 Introduction of High-Tech Products for Transplantation
5.4 Future Trends
5.4.1 Rising Initiatives from Various Organizations and Governments
5.5 Impact Analysis
6. Corneal Transplantation Market - Global Analysis
6.1 Global Corneal Transplantation Market Revenue Forecast and Analysis
6.2 Global Corneal Transplantation Market Revenue Forecast and Analysis
6.3 Market Positioning of Key Players
7. Corneal Transplantation Market Analysis - By Type
7.1 Overview
7.2 Corneal Transplantation Market Revenue Share, by Product Type (2021 and 2028)
7.3 Penetrating Keratoplasty
7.3.1 Overview
7.3.2 Penetrating Keratoplasty: Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Descemet Membrane Endothelial Keratoplasty (DMEK)
7.4.1 Overview
7.4.2 Descemet Membrane Endothelial Keratoplasty (DMEK): Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Descemet Stripping Endothelial Keratoplasty (DSEK)
7.5.1 Overview
7.5.2 Descemet Stripping Endothelial Keratoplasty (DSEK): Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Corneal Limbal Stem Cell Transplant
7.6.1 Overview
7.6.2 Corneal Limbal Stem Cell Transplant: Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
8. Corneal Transplantation Market Analysis - By Indication
8.1 Overview
8.2 Corneal Transplantation Market Revenue Share, by Indication (2021 and 2028)
8.3 Fungal Corneal Ulcer
8.3.1 Overview
8.3.2 Fungal Corneal Ulcer: Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Fuchs Dystrophy
8.4.1 Overview
8.4.2 Fuchs Dystrophy: Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Keratoconus
8.5.1 Overview
8.5.2 Keratoconus: Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Keratitis
8.6.1 Overview
8.6.2 Keratitis: Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
9. Corneal Transplantation Market Analysis - By End User
9.1 Overview
9.2 Corneal Transplantation Market Share, by End User, 2021 and 2028, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Eye Clinics
9.4.1 Overview
9.4.2 Eye Clinics: Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Corneal Transplantation Market - Revenue and Forecast to 2028 (US$ Million)
10. Global Corneal Transplantation Market - Geographic Analysis
11. Impact of COVID-19 Pandemic on Global Corneal Transplantation Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Corneal Transplantation Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 CorneaGen
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Alcon Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Florida Lions Eye Bank
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Corneat Vision
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Aurolab
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 KERAMED, INC.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 CORNEA BIOSCIENCES, INC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 EYEMEDICS
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Massachusetts Eye and Ear
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Lifeline Scientific, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 San Diego Eye Bank
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/vi36ut
Attachment
